Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease

Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease

Abstract Aims Sacubitril/valsartan (SV) reduced heart failure hospitalization and cardiovascular mortality compared with enalapril in the Prospective Comparison of ARNI with ACE‐I to Determine Impact on Global Mortality and Morbidity in Heart Failure trial. However, this trial excluded patients with...

Full description

Bibliographic Details
Main Authors: Seonhwa Lee, Jaewon Oh, Hyoeun Kim, Jaehyung Ha, Kyeong‐hyeon Chun, Chan Joo Lee, Sungha Park, Sang‐Hak Lee, Seok‐Min Kang
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:ESC Heart Failure
Subjects:
Sacubitril/valsartan
Heart failure with reduced ejection fraction patients
End‐stage renal disease
Dialysis
Online Access:https://doi.org/10.1002/ehf2.12659

Internet

https://doi.org/10.1002/ehf2.12659

Similar Items